RHEUMATOID FACTOR

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

AUTOIMMUNE.

Synonyms/Aliases

RHEUMATOID ARTHRITIS FACTOR, RA LATEX, RF TITER.

Abbreviations

RF.

Type

INDIVIDUAL TEST.

2-3 HRS

2-3 HOURS

Method

LATEX AGGLUTINATION.

Temp

AMBIENT (48 HOURS), REFRIGERATED (7-14 DAYS), FROZEN (>30 DAYS).

Setup

ALL WORKING DAYS.

Components Parameters

N/A.

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

N/A.

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE; TITRES ARE PROVIDED FOR POSITIVE CASES.

Clinical Utility

EVALUATE RHEUMATOID ARTHRITIS (RA) AS ONE COMPONENT OF A MULTI-CRITERIA DIAGNOSTIC PROCESS THAT CO-OPTS CLINICAL & OTHER LAB CRITERIA (REFER TO CURRENT ACR/ EULAR CRITERIA FOR DIAGNOSIS OF RHEUMATOID ARTHRITIS). IT IS LESS SPECIFIC FOR RA THAN ANTI-CCP.

Test Limitations/ Confounders

FALSE POSITIVES MAY OCCUR IN CHRONIC INFLAMMATORY STATES, OTHER AUTOIMMUNE DISEASES, IN SOME NORMAL INDIVIDUALS ETC.

PROTEINASE 3 ANTIBODY, ELISA

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

AUTOIMMUNE.

Synonyms/Aliases

C-ANCA-SPECIFIC ANTIBODY.

Abbreviations

PR3-ANCA, c-ANCA.

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS

Method

IMMUNOASSAY.

Temp

AMBIENT (24 HOURS), REFRIGERATED (3 DAYS), FROZEN (30 DAYS).

Setup

BATCHED.

Components Parameters

N/A.

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

N/A.

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

DIAGNOSIS OF WEGENER GRANULOMATOSIS.

Test Limitations/ Confounders

N/A.

MYOSITIS PROFILE

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

AUTOIMMUNE.

Synonyms/Aliases

MYOSITIS PANEL.

Abbreviations

N/A

Type

PROFILE/ PANEL (BUNDLED TESTS).

10 DAYS

10 WORKING DAYS

Method

IMMUNOBLOT.

Temp

AMBIENT (25℃):1DAY; R (2℃-8℃): 14 DAYS; F (-20℃): 30 DAYS.

Setup

BATCHED.

Components Parameters

Jo-1 (HISTIDYL-tRNA SYNTHETASE), Mi-2 (NUCLEAR-HELICASE PROTEIN), PL-7 (THREONYL-tRNA SYNTHETASE), PL-12 (ALANYL-tRNA SYNTHETASE), Ku, EJ (GLYCYL-tRNA SYNTHETASE), OJ (ISOLEUCYL-tRNA SYNTHETASE), SRP (SIGNAL RECOGNITION PARTICLE), PM/Scl 100, PM Scl 75, Ro52 (SSA-52) ANTIBODIES.

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY. MENTION ANA RESULT IF AVAILABLE.

Patient preparation

NOT APPLICABLE.

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

AT LEAST 3 ML

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

EVALUATION OF SUSPECTED INFLAMMATORY MYOPATHIES & AUTOIMMUNE MYOSITIS (DERMATOMYOSITIS, POLYMYOSITIS).

Test Limitations/ Confounders

N/A.

MYELOPEROXIDASE (MPO) ANTIBODY, ELISA

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

AUTOIMMUNE.

Synonyms/Aliases

PERINUCLEAR ANTI-CYTOPLASMIC ANTIBODIES.

Abbreviations

MPO AB; MPO-ANCA; p-ANCA.

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS

Method

IMMUNOASSAY

Temp

AMBIENT (1 HOURS), REFRIGERATED (7 DAYS), FROZEN (30 DAYS).

Setup

BATCHED.

Components Parameters

N/A.

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

FASTING 8-10 HOURS.

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

3 ML

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

DIAGNOSIS OF VARIOUS AUTOIMMUNE VASCULITIC DISORDERS.

Test Limitations/ Confounders

N/A.

MYASTHENIA GRAVIS PROFILE

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

AUTOIMMUNE.

Synonyms/Aliases

MYASTHENIA GRAVIS PANEL.

Abbreviations

N/A

Type

PROFILE/ PANEL (BUNDLED TESTS).

7 DAYS

7 WORKING DAYS

Method

RADIOIMMUNOASSAY.

Temp

REFRIGERATED OR FROZEN.

Setup

BATCHED.

Components Parameters

1) MUSCLE SPECIFIC KINASE (MuSK) ANTIBODY, 2) ANTI SKELETAL (STRIATED) MUSCLE ANTIBODY (ASKA), 3) ACETYLCHOLINE RECEPTOR (AChR) ANTIBODY.

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

N/A.

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

AT LEAST 5ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

TO DIAGNOSE GENERALIZED AND OCULAR MYASTHENIA GRAVIS. TO DISTINGUISH MYASTHENIA GRAVIS FROM OTHER CONDITIONS WITH SIMILAR SYMPTOMS.

Test Limitations/ Confounders

10-15% OF PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS AND 25-50% OF PATIENTS WITH OCULAR MYASTHENIA ARE SERONEGATIVE FOR ACHR BUT MAY BE SEROPOSITIVE FOR OTHER MARKERS E.G. MuSK.

MUMPS VIRUS ANTIBODY, IgG

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

MUMPS IgG.

Abbreviations

N/A

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS

Method

IMMUNOASSAY.

Temp

AMBIENT (6 HOURS), REFRIGERATED (3 DAYS), FROZEN (30 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY. SPECIFY EXACT ANTIBODY TYPE REQUIRED E.G. MUMPS IgG RATHER THAN MUMPS SEROLOGY.

Patient preparation

N/A.

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

APPROPRIATE VALUES PROVIDED WITH REPORT.

Clinical Utility

IgG POSITIVITY IS CONSISTENT WITH VACCINATION OR PAST EXPOSURE TO MUMPS VIRUS (IS EVIDENCE OF IMMUNITY AGAINST MUMPS).

Test Limitations/ Confounders

N/A.

MITOCHONDRIAL (M2) ANTIBODY

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

AUTOIMMUNE.

Synonyms/Aliases

ANTIMITOCHONDRIAL ANTIBODIES.

Abbreviations

AMA.

Type

INDIVIDUAL TEST.

7 DAYS

7 WORKING DAYS

Method

IMMUNOFLUORESCENCE.

Temp

AMBIENT (6 HOURS), REFRIGERATED (7 DAYS), FROZEN (14 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

FASTING SAMPLE PREFERED.

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

DIAGNOSIS OF PRIMARY BILIARY CHOLANGITIS.

Test Limitations/ Confounders

IMMUNE COMPLEXES IN THE SAMPLE MAY RESULT TO FALSE POSITIVE RESULTS.

MEASLES ANTIBODY, IgG

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

RUBEOLA IgG, MEASLES IgG.

Abbreviations

N/A.

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS

Method

IMMUNOASSAY.

Temp

AMBIENT (6 HOURS), REFRIGERATED (7 DAYS), FROZEN (30 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY. SPECIFY EXACT ANTIBODY TYPE REQUIRED E.G. MEASLES IgG RATHER THAN MEASLES SEROLOGY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

APPROPRIATE VALUES PROVIDED WITH REPORT.

Clinical Utility

IgG POSITIVITY IS CONSISTENT WITH VACCINATION OR PAST EXPOSURE TO MEASLES VIRUS (IS EVIDENCE OF IMMUNITY AGAINST MEASLES).

Test Limitations/ Confounders

N/A

LEISHMANIA (KALA-AZAR), rK39 SEROLOGY TEST

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

LEISHMANIA DONOVANI IgG.

Abbreviations

L. DONOVANI IgG.

Type

INDIVIDUAL TEST.

7 DAYS

7 WORKING DAYS

Method

IMMUNOCHROMATOGRAPHY.

Temp

AMBIENT (24 HOURS), REFRIGERATED (7 DAYS), FROZEN (10 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

DIAGNOSIS OF VISCERAL LEISHMANIASIS (KALA-AZAR).

Test Limitations/ Confounders

FALSE NEGATIVE RESULTS CAN OCCUR AND IF THERE IS A HIGH INDEX OF SUSPICION, FURTHER DIAGNOSTIC WORK-UP IS REQUIRED.

Jo 1 ANTIBODY, IgG

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

AUTOIMMUNE.

Synonyms/Aliases

Jo 1 ANTIBODIES, IgG, POLYMYOSITIS ANTIBODIES.

Abbreviations

ANTI-Jo-1.

Type

INDIVIDUAL TEST.

7 DAYS

7 WORKING DAYS

Method

IMMUNOASSAY.

Temp

AMBIENT (24 HOURS), REFRIGERATED (7 DAYS), FROZEN (10 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY. PROVIDE ANA RESULTS IF DONE.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

EVALUATION OF SUSPECTED POLYMYOSITIS, DERMATOMYOSITIS OR MYOSITIS WITH INTERSTITIAL LUNG DISEASE/ PULMONARY FIBROSIS.

Test Limitations/ Confounders

N/A.